GI Stool Testing Market Worldwide Industry Analysis, Future Demand and Forecast till 2029

 The global GI stool testing market is anticipated to grow at a considerable CAGR of 7.1% during the forecast period (2023-2029). Gastrointestinal infections (GI) are caused by a variety of viruses, bacteria, and parasites. The gastrointestinal pathogen panel simultaneously tests for the presence of multiple disease-causing (pathogenic) microbes in a stool sample. The GI pathogen panel detects the genetic material (RNA or DNA) of some of the more common pathogens. It can identify co-infections (more than one microbe causing the infection) and identify microbes that might be missed with traditional testing. The rising prevalence of diarrhea across the globe is expected to raise the demand for the GI stool testing market during the forecast period. For instance, according to the World Health Organization, diarrheal disease is the second leading cause of death in children under five years old. Globally, there are nearly 1.7 billion cases of childhood diarrheal disease every year. Moreover, each year diarrhea kills around 5,25,000 children under five.

The technological advancements by market players across the globe are expected to hold a prominent share of the market during the forecast period. For instance, in January 2022, Exact Sciences Corp. announced performance data for a second-generation Cologuard (multi-target stool DNA) test showing overall sensitivity of 95.2% for colorectal cancer (CRC) at the specificity of 92.4% for negative samples confirmed by colonoscopy. Furthermore, Cologuard is the first and only FDA-approved, non-invasive stool DNA test used to screen average-risk people for CRC. Exact Sciences is developing a second-generation Cologuard to improve the specificity and precancer sensitivity of the test, decreasing the false positive rate and increasing the detection rate of precancerous lesions.

To Request a Sample of our Report on GI Stool Testing Market:  https://www.omrglobal.com/request-sample/gi-stool-testing-market

Market Coverage

                 The market number available for – 2021-2029

                 Base year- 2021

                 Forecast period- 2023-2029

Segment Covered- 

·                  By Product Type

·                  By Test Type

·                  By End-Users

Regions Covered-

·                  North America

·                  Europe

·                  Asia-Pacific

·                  Rest of the World

                 Competitive Landscape- including Abbott Laboratories, Alere, Inc., Cardinal Health, Inc., Cenogenics Corp., DiaSorin S.p.A, Diagnostic Solutions Laboratory, LLC, Epitope Diagnostics Inc., Siemens Healthcare, and others.

A full Report of GI Stool Testing Market is Available @  https://www.omrglobal.com/industry-reports/gi-stool-testing-market

GI Stool Testing Market Report Segment

By Product Type

                 Instruments

                 Reagents)

By Test Type

                 Microscopy

                 Occult Blood Test

                 Ova and Parasites Test

                 Bacteria Test

                 Fecal Biomarkers Test

                 Other Test Types

By End-Users 

                 Hospitals

                 Home

                 Diagnostic Centers & Laboratories

                 Academic Institutions and Research Centers

GI Stool Testing Market Report Segment by Region

North America                                                                                                           

·        United States

·        Canada                     

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan              

·                  South Korea

·                  Rest of APAC

Rest of the World

       Latin America

       Middle East and Africa 

Company Profiles 

                 Abbott Laboratories 

                 Alere, Inc. 

                 Beckman Coulter Inc. 

                 bioMerieux SA 

                 Biometrix Labs 

                 Bio-Rad Laboratories 

                 Cardinal Health, Inc. 

                 Cenogenics Corp. 

                 CTK Biotech Inc. 

                 Danaher Corp. 

                 DiaSorin S.p.A

                 Diagnostic Solutions Laboratory, LLC 

                 Epitope Diagnostics Inc. 

                 Genova Diagnostics Inc. 

                 Meridian Bioscience Inc. 

                 Oasis Health & Wellness

                 Quest Diagnostics Inc. 

                 RN Labs Pty Ltd. 

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/gi-stool-testing-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

 

Comments

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025